Clinical Trial

Determination of the Minimal Detectable Change of the Parkinson's Disease Questionnaire-8

Recruiting
View on ClinicalTrials.gov →
Summary
This study is conducted to determine how many units of improvement the Parkinson's Disease Questionnaire-8 (PDQ-8), used to evaluate the quality of life of Parkinson's patients, should have to express a significant change in the quality of life. Patients for whom a 30-session physiotherapy program is recommended will be included in the study. Patients will be asked to express the change in their quality of life at the end of treatment. The PDQ-8 survey and Global Rating of Patient-Perceived Changes (GRP-PC) forms will be used to determine these changes. Evaluations will be repeated at the beginning of the treatment program and at the end of the 30th session.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-07-03.
Trial Details
NCT Number NCT06487364
Lead Sponsor Emre Şenocak
Conditions Parkinson Disease
Enrollment 39 participants
Start Date 2024-05-13
Primary Completion 2025-01-17 (estimated)
Study Completion 2025-09-17 (estimated)
Updated on ClinicalTrials.gov 2025-03-05